Creighton University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Creighton University sits in the top decile of US sponsors by registered trial count (#243 of 15,742 sponsors by registered trial count).
Creighton University: 98 sponsored US clinical trials, 5 recruiting.
Creighton University sponsors 98 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 85 completed. 21 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteopenia, with 2 trials.
Top-decile sponsor footprint
Creighton University ranks in the top decile of sponsors by registered trial count (#243 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
85 of 92 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
98 total, page 2 of 2
Vitamin D Replacement: The Effect on Statin-Related Myalgias
NCT01022398
Relative Efficacy of Vitamins D2 and D3 in Adult Humans
NCT01139840
The Effect of Weight on Vitamin D Dose Response
NCT01013584
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
NCT01018849
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
NCT01052051
The Use of Rosiglitazone to Treat Asthma
NCT00614874
The Impact of Grapefruit Juice on the Response to Clopidogrel
NCT00817999
Aspirin Responsiveness in Women at Risk for Cardiac Events
NCT00818337
Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation
NCT00818012
Adequate Dairy Intake on Weight Change in Girls
NCT01066806
Environmental Influences on Vitamin D Status
NCT00780247
UVB Light and Sunscreen
NCT00818467
Bone Health in Type 1 Diabetes
NCT00651196
Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment
NCT00650780
Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease
NCT00511225
Roflumilast In-Vitro Basophil Release
NCT00613587
Sunlight Exposures Effect on Serum Vitamin D Levels
NCT00473317
Vitamin D Supplementation in Older Women
NCT00472823
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
NCT00980031
The Effect of Xolair (Omalizumab) on Allergy Blood Cells
NCT00657891
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
NCT00399776
The Pharmacokinetics of a Single Large Dose of Vitamin D3
NCT00473239
Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents
NCT00573716
T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy
NCT00589849
Augmentation in Tx-resistant OCD: an Open Label Trial
NCT00590642
Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia
NCT00590408
Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
NCT00352469
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
NCT00139152
Black Education and Treatment of Hypertension (BEAT HTN)
NCT00661895
Mometasone and Markers of Airway Inflammation
NCT00711165
Abilify Therapy for Reducing Comorbid Substance Abuse
NCT00208169
Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study
NCT00590616
Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
NCT00590525
Adding Phosphorus to Osteoporosis Drug Treatment
NCT00074711
Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia
NCT00613795
Depakote ER Therapy for Mania Comorbid With Substance Abuse
NCT00208195
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
NCT00208143
Geodon (Ziprasidone) for Posttraumatic Stress Disorder
NCT00208208
Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits
NCT00476346
Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians
NCT00208130
Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma
NCT00208182
Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices
NCT00661856
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
NCT00263250
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
NCT01922674
Study of the Effect of a Calcium-rich Diet on Bone Health in Girls
NCT01058109
Treatment of Calcium Deficiency in Young Women
NCT00000426
To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study
NCT07660536
Study to Determine How Exercise and Calcium Affect Pubertal Bone
NCT01087138
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 3 |
| Phase 4 | 18 |
Where Creighton University enrollment is open (later-stage tilt)
5 recruiting of 98 indexed (5% open); 85 completed (87%).
Phase mix: 21 late (III/IV) vs 7 early (I/II) (later-stage heavy).
Top condition: Osteopenia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Creighton University: open-pipeline peers nationwide
Peers matched on 98 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Creighton University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 98 trials (± recruiting share)
- GE Healthcare · 99 trials · 8% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- UCB Pharma · 100 trials · 0% recruiting
- Wake Forest University · 100 trials · 7% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Gilead Sciences · 5% recruiting · 504 trials
- Avera McKennan Hospital & University Health Center · 5% recruiting · 20 trials
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Integra LifeSciences Corporation · 5% recruiting · 60 trials
Related
What to do with this Creighton University page
98 registered trials is a research-attention snapshot, not an endorsement of Creighton University or any single study.
- 5 of Creighton University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Osteopenia is the condition Creighton University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteopenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Creighton University pipeline card: 98 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.